MedTrace Logo

EXhaled Hydrogen Peroxide As a Marker of Lung diseasE (EXHALE) Pilot Study.

NCT03055923 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 149

Last updated 2023-04-07

No results posted yet for this study

Summary

This Pilot study evaluates the use of a new device called Inflammacheck and whether it can consistently measure hydrogen peroxide levels in exhaled breath condensate. It will also assess whether exhaled breath condensate hydrogen peroxide levels as measured by Inflammacheck can differentiate people with asthma and COPD from healthy individuals.

Conditions

Interventions

DEVICE

The Inflammacheck Device

A new hand-held, Non-invasive breathing test, that only requires tidal breathing.

Sponsors & Collaborators

  • Asthma UK

    collaborator OTHER

  • Portsmouth Hospitals NHS Trust

    lead OTHER_GOV

Principal Investigators

  • Prof Anoop J Chauhan · Portsmouth Hospitals NHS Trust

Eligibility

Min Age
16 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2016-11-14
Primary Completion
2018-04-10
Completion
2018-04-10

Countries

  • United Kingdom

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03055923 on ClinicalTrials.gov